Edition:
India

Profile: Caplin Point Laboratories Ltd (CAPL.BO)

CAPL.BO on Bombay Stock Exchange

584.80INR
7 Aug 2020
Change (% chg)

Rs-45.80 (-7.26%)
Prev Close
Rs630.60
Open
Rs649.00
Day's High
Rs686.00
Day's Low
Rs567.55
Volume
594,043
Avg. Vol
35,292
52-wk High
Rs686.00
52-wk Low
Rs180.00

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and Ovules, Powder for Injection, Dry syrup, Topicals, Liquid Injections, Inhalers, intravenous (IV) Infusion, Lyophilized Products, Branded Products, Dermo Cosmetics and Other Products. It also manufactures a range of ointments, creams, gels and lotions. The Company has presence in Latin American nations of Guatemala, Honduras, Nicaragua, El Salvador, Ecuador, Honduras, Venezuela and Dominican Republic. The Company's manufacturing facilities are located in Suthukeny village, Puducherry; Gummidipoondi Taluk, Tamil Nadu, and Baddi, Himachal Pradesh. Its research and development units are located in Gummidipoondi Taluk, Tamil Nadu.

Company Address

Caplin Point Laboratories Ltd

NARBAVI
No. 3, Lakshmanan Street, T. Nag
CHENNAI     600017
P: +9144.28156653
F: +9144.28154952

Company Web Links